Skip to search.
 FTSE 100 Down 1.37%

Edwards Lifesciences Corp. (EW)

-NYSE
141.94 Down 0.31(0.22%) 19:18 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:142.25
Open:140.78
Bid:141.88 x 200
Ask:141.97 x 200
1y Target Est:143.74
Beta:0.56
Earnings Date:22 Apr - 27 Apr (Est.)
Day's Range:138.13 - 142.80
52wk Range:70.29 - 150.41
Volume:669,632
Avg Vol (3m):981,852
Market Cap:15.31b
P/E (ttm):18.98
EPS (ttm):7.48
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EWDown 0.22%15.31b
ICUIUp 0.76%1.43b
MDTDown 0.63%75.56b
STJDown 0.18%18.37b

Key Statistics

Forward P/E (1 yr):30.32
P/S (ttm):6.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.21
Quarterly EPS Est (Mar-15) :1.04
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback